Myocardial reperfusion is a pivotal component of cardiovascular care, encompassing the reinstatement of blood flow to the heart muscle following a period of ischemia. Ischemia arises when the blood supply to the heart is temporarily diminished or obstructed, often in the context of a myocardial infarction (heart attack). The primary goal of reperfusion is to alleviate ischemic conditions and mitigate damage to the cardiac tissue. Nonetheless, the restoration of blood flow during reperfusion is a double-edged sword. The abrupt reintroduction of oxygen to the ischemic tissue can trigger oxidative stress and inflammation, contributing to additional injury. Striking a balance between the benefits of reperfusion and the potential harm it may cause is a central challenge in managing cardiovascular diseases.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain